Analyst Articles – US

Cantor Fitzgerald Reaffirms “Overweight” Rating for Zimmer Biomet (ZBH)

Zimmer Biomet (NYSE:ZBH)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a report released on Tuesday. A number of other equities research analysts also recently weighed in on ZBH. Morgan Stanley lifted their price objective on Zimmer Biomet from $140.00 to $149.00 and gave the company an “overweight” rating in […]

Enanta Pharmaceuticals (ENTA) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Enanta Pharmaceuticals (NASDAQ:ENTA) from a sell rating to a hold rating in a report released on Friday. According to Zacks, “Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory […]

Docusign (DOCU) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of Docusign (NASDAQ:DOCU) from a hold rating to a sell rating in a research note released on Friday morning. According to Zacks, “DocuSign Inc. provides e-signature solutions. The Company offers services to mortgage, non-profit, government, real estate, insurance, technology and healthcare industries. Its product portfolio includes trial, single-user, multi-user, business […]

Argus Reaffirms “Buy” Rating for BB&T (BBT)

Argus reiterated their buy rating on shares of BB&T (NYSE:BBT) in a research report sent to investors on Friday morning. Other equities analysts have also issued research reports about the company. Zacks Investment Research upgraded BB&T from a hold rating to a buy rating and set a $55.00 price target for the company in a […]

Regeneron Pharmaceuticals (REGN) Raised to B at TheStreet

TheStreet upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN) from a c+ rating to a b rating in a research report released on Thursday morning. REGN has been the subject of several other reports. Cantor Fitzgerald upped their price target on shares of Regeneron Pharmaceuticals to $441.00 and gave the stock a neutral rating in a report […]

Salem Media Group (SALM) Cut to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Salem Media Group (NASDAQ:SALM) from a buy rating to a hold rating in a research note published on Friday morning. According to Zacks, “Salem Media Group, Inc. is a radio broadcaster, Internet content provider and magazine and book publisher specializing in Christian and Conservative content. Its operating segment consists […]

SUNDANCE ENERGY/S (SNDE) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of SUNDANCE ENERGY/S (NASDAQ:SNDE) from a strong sell rating to a hold rating in a report published on Wednesday. According to Zacks, “Sundance Energy Australia Limited is focused on the acquisition and development of oil and gas. Its asset primarily located in premier North American resource plays. Sundance Energy Australia […]

Zacks Investment Research Lowers HMS (HMSY) to Hold

Zacks Investment Research cut shares of HMS (NASDAQ:HMSY) from a buy rating to a hold rating in a research note issued to investors on Friday. According to Zacks, “HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful […]

Tata Motors (TTM) Upgraded to “Hold” at Zacks Investment Research

Tata Motors (NYSE:TTM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. According to Zacks, “Tata Motors is India’s leading automotive manufacturer. “ Other analysts have also issued reports about the company. ValuEngine raised Tata Motors from a “hold” […]

GN STORE NORD A/ADR (GNNDY) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of GN STORE NORD A/ADR (OTCMKTS:GNNDY) from a sell rating to a hold rating in a report released on Friday. According to Zacks, “GN Store Nord A/S offers medical hearing instruments, professional and consumer headsets. The Company’s operating segments include GN Netcom, GN ReSound and Others. GN Netcom segment sells […]

Smart Global (SGH) Receives Hold Rating from Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of Smart Global (NASDAQ:SGH) in a report published on Wednesday morning. Several other brokerages also recently weighed in on SGH. Roth Capital lowered their price target on Smart Global from $60.00 to $40.00 and set a buy rating for the company in a report on […]

Zacks Investment Research Lowers IMPINJ (PI) to Hold

Zacks Investment Research lowered shares of IMPINJ (NASDAQ:PI) from a buy rating to a hold rating in a research note issued to investors on Wednesday. According to Zacks, “Impinj, Inc. is a provider of referral and information network radio frequency identification solutions to the retail, pharmaceutical, healthcare, food and beverage and other industries. The company’s […]

Rosehill Resources (ROSE) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Rosehill Resources (NASDAQ:ROSE) from a hold rating to a buy rating in a report issued on Wednesday. They currently have $3.50 target price on the stock. According to Zacks, “Rosehill Resources Inc. is an oil and gas exploration company. Its principally producing assets located in Texas and New Mexico […]

Goldman Sachs Group Begins Coverage on DTE Energy (DTE)

Goldman Sachs Group initiated coverage on shares of DTE Energy (NYSE:DTE) in a report published on Wednesday, MarketBeat reports. The brokerage issued a buy rating and a $121.00 price target on the utilities provider’s stock. Several other equities research analysts also recently weighed in on the stock. ValuEngine downgraded shares of DTE Energy from a […]

Flowserve (FLS) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Flowserve (NYSE:FLS) from a buy rating to a hold rating in a research note published on Wednesday morning. According to Zacks, “We believe that Flowserve is well positioned to benefit from strengthening end markets as well as realignment and transformational initiatives in the long run. Also, the combined businesses […]

FirstEnergy (FE) Cut to Hold at Zacks Investment Research

Zacks Investment Research cut shares of FirstEnergy (NYSE:FE) from a buy rating to a hold rating in a report published on Wednesday. According to Zacks, “In the past 12 months, shares of FirstEnergy have outperformed its industry.  FirstEnergy is now reporting as a fully-regulated utility company.  The company’s modernization drive and ambitious Energizing the Future […]

Maxim Integrated Products (MXIM) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Maxim Integrated Products (NASDAQ:MXIM) from a sell rating to a hold rating in a report issued on Wednesday. According to Zacks, “Maxim's high dependence on Samsung is a risk to its growth trajectory. Also, the company is suffering from sluggish bookings and weakening momentum across its customers. These are […]

Wedbush Reaffirms Buy Rating for Logitech International (LOGI)

Wedbush restated their buy rating on shares of Logitech International (NASDAQ:LOGI) in a research report sent to investors on Wednesday. They currently have a $40.00 target price on the technology company’s stock. LOGI has been the subject of several other reports. Zacks Investment Research cut Logitech International from a strong-buy rating to a hold rating […]

Ingles Markets (IMKTA) Raised to “Sell” at ValuEngine

ValuEngine upgraded shares of Ingles Markets (NASDAQ:IMKTA) from a strong sell rating to a sell rating in a research note published on Wednesday. A number of other brokerages also recently issued reports on IMKTA. BidaskClub downgraded Ingles Markets from a hold rating to a sell rating in a research note on Tuesday, November 20th. Zacks […]

Mercadolibre’s (MELI) “Buy” Rating Reiterated at BTIG Research

BTIG Research reissued their buy rating on shares of Mercadolibre (NASDAQ:MELI) in a report released on Wednesday morning, The Fly reports. The brokerage currently has a $410.00 price objective on the stock. Several other brokerages have also recently issued reports on MELI. Zacks Investment Research upgraded shares of Mercadolibre from a strong sell rating to […]

Obseva (OBSV) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of Obseva (NASDAQ:OBSV) from a hold rating to a sell rating in a report issued on Wednesday morning. According to Zacks, “ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman’s reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, […]

Devon Energy (DVN) Rating Lowered to Equal Weight at Barclays

Barclays cut shares of Devon Energy (NYSE:DVN) from an overweight rating to an equal weight rating in a research report sent to investors on Wednesday, MarketBeat.com reports. Barclays currently has $33.00 price target on the energy company’s stock, down from their previous price target of $42.00. Several other equities research analysts have also recently issued […]

New Age Beverages (NBEV) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research lowered shares of New Age Beverages (NASDAQ:NBEV) from a hold rating to a sell rating in a research report sent to investors on Wednesday. According to Zacks, “New Age Beverages Corporation is a beverage company. The company’s brand portfolio include XingTea (R) , Aspen Pure (R) , Artesian Water, Búcha (R) Live […]

Johnson & Johnson (JNJ) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of Johnson & Johnson (NYSE:JNJ) from a hold rating to a sell rating in a research report released on Wednesday. According to Zacks, “J&J’s Pharma unit is performing better than the market while the Medical Devices and Consumer units are seeing improving organic growth trends. However, headwinds like generics competition, […]

Iamgold (IAG) Earns “Buy” Rating from Credit Suisse Group

Credit Suisse Group restated their buy rating on shares of Iamgold (NYSE:IAG) (TSE:IMG) in a research note released on Wednesday morning. The firm currently has a $6.00 price objective on the mining company’s stock. Other equities analysts have also recently issued reports about the company. ValuEngine upgraded Iamgold from a sell rating to a hold […]